Crossmark

Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study

Crossref DOI link: https://doi.org/10.1007/s00432-021-03831-z

Published Online: 2021-10-20

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Hao

Zhou, Xiaojuan

Yang, Hui

Gong, Youling

Wang, Jin

Xu, Yong

Zhou, Lin

Xue, Jianxin

Zou, Bingwen

Zhang, Yan

Zhu, Jiang

Peng, Feng

Huang, Meijuan

Lu, You

Liu, Yongmei https://orcid.org/0000-0001-6033-8343
License Information

Text and Data Mining valid from 2021-10-20

Version of Record valid from 2021-10-20
More Information

Article History

Received: 6 June 2021

Accepted: 10 October 2021

First Online: 20 October 2021

Declarations

:

: The authors declare that they have no conflict of interest.

: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of the West China Hospital of Sichuan University.

: The authors ensure transparency and availability of data.

: R version 4.03 software was used and measurement data.

Document is current

Any future updates will be listed below